Program Hotline (877)300-7044
Sober Living (800)662-HELP
Ultram Addiction
Q)
What is Ultram?
A)
Ultram is the brand name of the generic drug Tramadol
(TRA-ma-doll). Ultram is an analgesic used to treat or
prevent pain. Ultram is not a non steroidal anti inflammatory
drug, nor is it a narcotic.
Q)
How does Ultram work?
A)
Ultram binds to certain opiod pain receptors in the body.
By blocking the reuptake of the neuro chemicals norepinephrine
and serotonin, it modifies the pain message resulting
in pain relief.
Q)
What are the side effects of Ultram?
A)
The side effects of Ultram are: dizziness, nausea, drowsiness,
dry mouth, constipation, headache, sweating, difficulty breathing
or tightness of chest; swelling of eyelids, face, or lips, a
develop of a rash or hives.
Q)
What are the symptoms of an Ultram overdose?
A)
The symptoms of an overdose of Ultram are: skin rash, itching,
seizures, hallucinations, cold and clammy skin, low body temperature,
slowed breathing, slowed heartbeat, drowsiness, dizziness, lightheadedness,
seizures, deep sleep, and loss of consciousness.
Q)
Is Ultram addictive?
A)
Introduced in 1995, no control was recommended based on review
of its uncontrolled use in 40 other countries. However, once
released in the U.S., abuse became readily apparent. It is addictive.
It is a "non-narcotic" pain reliever. Large doses
can interfere with ability to breathe, especially if taken with
alcohol.
People dependent on narcotics may experience drug withdrawal
symptoms if they take Ultram. This central acting synthetic
analgesic, opiate-type pain reliever has affinity, although
low, for opiate receptors and has other mechanisms of function
as well.
Q)
What medical complications come with the abuse of Ultram?
A)
Seizures have been reported in patients receiving ULTRAM. The
risk of seizures is increased with doses of ULTRAM above the
recommended range. ULTRAM increases the seizure risk in patients
taking certain medications (e.g. tricyclic antidepressants,
selective serotonin reuptake inhibitors, opioids) and may enhance
the seizure risk in patients taking MAO inhibitors, neuroleptics,
or other drugs that reduce the seizure threshold or in patients
with a medical history that may suggest increased risk of seizure.
|
